CYTARABINE ACCORD 100 mg/ml, solution for injection or infusion bottle, 20 ml
Active ingredients: Cytarabine
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for injection preparation or infusionbottle, 20 mlintraveineuse;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CYTARABINE ACCORD 100 mg/ml, solution injectable ou pour perfusion
- Pharmaceutical form
- solution pour préparation injectable ou pour perfusion
- Route of administration
- intraveineuse;sous-cutanée
- Presentation description
- 1 flacon(s) en verre de 20 mL
- Marketing authorisation holder
- ACCORD HEALTHCARE FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 21 Oct 2013
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Prescribed by specialists only
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63318475CIP75853196CIP133400958531965Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CYTARABINEsolution | 100 mg · 1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.